Last reviewed · How we verify

NCT07031050: SPARO

Robotic Sacrocolpopexy and Sacrocervicopexy - an Observational Study to Confirm the Peri- and Postoperative Safety and Clinical Performance

Completed Last updated 13 April 2026
What this trial tests

trial testing sacrocolpopexy or sacrocervicopexy in Sacrocolpopexy in 35 participants. Completed in 6 January 2026.

Timeline
19 May 2025
Primary endpoint
6 January 2026
6 January 2026

Quick facts

Lead sponsorDistalmotion SA
StatusCompleted
Study typeOBSERVATIONAL
Enrollment35
Start date19 May 2025
Primary completion6 January 2026
Estimated completion6 January 2026
Sites6 locations across Switzerland, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Distalmotion SA

Who can join

18 and older, any sex, with Sacrocolpopexy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted sacrocolpopexy or sacrocervicopexy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sacrocolpopexy

Currently open trials in the same condition.

Other Distalmotion SA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07031050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing